Remedium Bio announces successful $2.3M Expanded Seed raise

/PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded...

Related Keywords

Boston , Massachusetts , United States , University Of Massachusetts , Timothy Mcalindon , Jeff Ellsworth , Frank Luppino , Prnewswire Remedium Bio Inc , Division Of Endocrinology , Division Of Rheumatology At Tufts Medical Center , Remedium Bio Inc , Primo Medical Group , Lipid Center At Tufts Medical , Professor At Tufts University School Of Medicine , Longevitytech Fund , Tufts University School Of Medicine , Apis Health Angels , Health Sciences , Tufts University School , Sherwood Ventures , Angel Star Ventures , Guindy Alumni , Remedium Bio , Tufts Medical Center , Anastassios Pittas , Lipid Center , Recardia Therapeutics , Professor Immunology , Kai Zou Phd , Assistant Professor , Nc ,